Results 151 to 160 of about 6,055,275 (250)

ÐÐРÐÐÐЯÐÐЯ ÐФÐÐТÐÐÐÐСТРСТÐÐÐÐРТÐÐÐ¥ ТРÐÐÐÐРÐЧÐÐÐ¥ РÐÐÐÐÐРХÐÐÐÐТÐРÐÐÐÐ ÐÐЯ 4-Ñ ÐÐÐÐÐЧÐÐÐ ÐÐТÐÐÐРÐÐ ÐÐЦÐÐÐТÐÐ Ð ÐÐСÐÐÐРРÐÐÐÐÐÐ ÐУÐЬТÐРÐÐÐСТÐÐТÐÐÐРТУÐÐРÐУÐЬÐÐУ

, 2013
Н.А. Литвиненко, С.О. Черенько, Л.М. Циганкова, Я.В. Вольський, О.Р. Тарасенко   +4 more
openalex   +2 more sources

Intein‐based modular chimeric antigen receptor platform for specific CD19/CD20 co‐targeting

Molecular Oncology, EarlyView.
CARtein is a modular CAR platform that uses split inteins to splice antigen‐recognition modules onto a universal signaling backbone, enabling precise, scarless assembly without re‐engineering signaling domains. Deployed here against CD19 and CD20 in B‐cell malignancies, the design supports flexible multi‐antigen targeting to boost T‐cell activation and
Pablo Gonzalez‐Garcia, Noelia Moares, Wenjie Yi‐He, Rosa Luna‐Espejo, Ricardo Fernandez‐Cisnal, Javier Ocaña‐Cuesta, Juan P. Muñoz‐Miranda, Antonio Gabucio, Cecilia M. Fernandez‐Ponce, Francisco Garcia‐Cozar   +9 more
wiley   +1 more source

Prognostic value of liver stiffness in patients with heart failure: a systematic review and meta-analysis. [PDF]

BMC Cardiovasc Disord
Stoleru IM, Mocan M, Crișan CH, Niculae LE, Chira RI.   +4 more
europepmc   +1 more source

ÐÑпекÑÑ Ð´Ð¸Ð°Ð³Ð½Ð¾ÑÑики и леÑÐµÐ½Ð¸Ñ ÑиÑÑÑгиÑеÑÐºÐ¸Ñ Ð³Ð½Ð¾Ð¹Ð½Ð¾-ÑепÑиÑеÑÐºÐ¸Ñ Ð¾Ñложнений пÑи вÑоÑиÑном иммÑнодеÑиÑиÑе.

, 2013
А. И. Краснослободский
openalex   +2 more sources

Improving PARP inhibitor efficacy in bladder cancer without genetic BRCAness by combination with PLX51107

Molecular Oncology, EarlyView.
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz, Anna L. Bartkowiak, Michael Rose, Nora Kolks, Patrick Petzsch, Vandana Solanki, Anne Stoffel, Bianca Faßbender, Leandra Lepping, Julka Volkamer, Karl Köhrer, Marc Seifert, Tokameh Mahmoudi, Tahlita C. M. Zuiverloon, Günter Niegisch, Michèle J. Hoffmann   +15 more
wiley   +1 more source

ÐолекÑлÑÑно-генеÑиÑеÑÐºÐ°Ñ Ñ Ð°ÑакÑеÑиÑÑика виÑÑÑов паÑагÑиппа, ÑиÑкÑлиÑÑÑÑÐ¸Ñ Ð½Ð° ÑеÑÑиÑоÑии СанкÑ-ÐеÑеÑбÑÑга и ÐенингÑадÑкой облаÑÑи

, 2016
Марина Алексеевна Махарова
openalex   +1 more source

Cytoplasmic p21 promotes stemness of colon cancer cells via activation of the NFκB pathway

Molecular Oncology, EarlyView.
Cytoplasmic p21 promotes colorectal cancer stem cell (CSC) features by destabilizing the NFκB–IκB complex, activating NFκB signaling, and upregulating BCL‐xL and COX2. In contrast to nuclear p21, cytoplasmic p21 enhances spheroid formation and stemness transcription factor CD133.
Arnatchai Maiuthed, Kerstin Huebner, Katharina Erlenbach‐Wuensch, Chuanpit Hampel, Daniela Thalheim, Adriana Vial‐Roehe, Bodee Nutho, Susanne Merkel, Arndt Hartmann, Pithi Chanvorachote, Regine Schneider‐Stock   +10 more
wiley   +1 more source

Tixutert n tmezgunt deg uselmed/almad n tutlayt n tmaziɣt. Amedya: Asif n tisselbi i d-yettwasuɣlen seg taɛrabt.

Ussnan
Amagrad-a yewwi-d ɣef txutert n uselmed/almad n tutlayt tmaziɣt s umezgun, amedya tamezgunt n Tawfik El-Hakim yettwasuɣlen ilmend n yidles amaziɣ. Tazrawt-a treṣṣa ɣef yinefkan n tsastant i nga s udiwenni d yiselmaden akked temsirin i neḥḍer deg tneɣrit.
Hassiba Kherbouche, Mohammed Agaoua
doaj  

Assessment of evidence from teeth and the alveolar bone of skulls. [PDF]

Sci Rep
Mânica S, García-Donas JG, Houlton T, Pandey H.   +3 more
europepmc   +1 more source

ÐÑÑледование Ñ Ð°ÑакÑеÑиÑÑик намагниÑÐ¸Ð²Ð°Ð½Ð¸Ñ ÑеÑÑомагнеÑиков в ÑложнÑÑ Ð¿ÑоÑÑÑанÑÑвеннÑÑ ÐºÐ¾Ð½ÑигÑÑаÑиÑÑ

, 2016
А. М. Сергеева
openalex   +1 more source